(Q38221290)

31 August 2017

title

The role of miRNAs in cancer: from pathogenesis to therapeutic implications (English)

1 reference

31 August 2017

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Mehmet Seven

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Omer Faruk Karatas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Mehmet Bugrahan Duz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

1 May 2014

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1027-1048

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24941988%20AND%20SRC:MED&resulttype=core&format=json

The function of microRNAs, small but potent molecules, in human prostate cancer.

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miRNA profiling of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Identification of novel genes coding for small expressed RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Causes and consequences of microRNA dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA regulatory networks and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Processing of primary microRNAs by the Microprocessor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The Microprocessor complex mediates the genesis of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Intronic microRNA precursors that bypass Drosha processing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

21 January 2018

Mammalian mirtron genes

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Nuclear export of microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The nuclear RNase III Drosha initiates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Dicer, Drosha, and outcomes in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Role for a bidentate ribonuclease in the initiation step of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Functional relevance of miRNA sequences in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Switching from repression to activation: microRNAs can up-regulate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A dicer-independent miRNA biogenesis pathway that requires Ago catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs direct rapid deadenylation of mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

21 January 2018

The microRNA Registry

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miRBase: microRNA sequences, targets and gene nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miRBase: tools for microRNA genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Functions of microRNAs and related small RNAs in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Detection of miR-106a in gastric carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Downregulation of microRNAs-143 and -145 in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miRNAs as biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiR-125 in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Review of miR-200b and cancer chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Widespread deregulation of microRNA expression in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Role of microRNAs in drug-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs and their target gene networks in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-221/222: promising biomarkers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Foxo3a regulates apoptosis by negatively targeting miR-21

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Lin28 promotes transformation and is associated with advanced human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Uncovering growth-suppressive MicroRNAs in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA145 targets BNIP3 and suppresses prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA and cancer--focus on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Gene networks and microRNAs implicated in aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Chromosomal alterations associated with the transition from in situ to invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

microRNA-34a is tumor suppressive in brain tumors and glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Identification of let-7-regulated oncofetal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Suppression of cell growth and invasion by miR-205 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The role of the miR-200 family in epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Genetic variation in microRNA networks: the implications for cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA expression profile of bronchioalveolar stem cells from mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Emerging role of microRNAs in cancer and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miRNA-708 control of CD44(+) prostate cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs as regulators of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs Associated with Metastatic Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Prognostic significance of serum miR-17-5p in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Biomarker testing for ovarian cancer: clinical utility of multiplex assays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Circulating miRNAs as new blood-based biomarkers for solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Circulating microRNAs in hematological diseases: principles, challenges, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Circulating microRNAs (miRNA) in serum of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs in immune regulation--opportunities for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Molecular pathways: microRNAs as cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNAs-449a and -449b exhibit tumor suppressive effects in retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Targeting miR-21 for the therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

RNAi: nature abhors a double-strand

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-34 - a microRNA replacement therapy is headed to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

The let-7 family of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Regression of murine lung tumors by the let-7 microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.259